Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1500
0.00 (0.00%)
Sep 18, 2026, 1:55 PM AEST
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 19.27 million as of September 17, 2026. Its market cap has decreased by -53.12% in one year.
Market Cap
19.27M
Enterprise Value
12.91M
Revenue
5.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
ChartMarket Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 19.27M, an increase of 1.28%. That is a compound annual growth rate of 0.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 19.27M | -49.15% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nexsen | 36.04M |
| Radiopharm Theranostics | 34.70M |
| Patrys | 23.62M |
| Proteomics International Laboratories | 23.15M |
| NeuroScientific Biopharmaceuticals | 22.99M |
| Imugene | 22.53M |
| EZZ Life Science Holdings | 20.47M |
| Noxopharm | 19.97M |